Arl13b Promotes Gastric Tumorigenesis by Regulating Smo Trafficking and Activation of the Hedgehog Signaling Pathway.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28611043.
- Also identified by DOI 10.1158/0008-5472.CAN-16-2461 and PMC identifier 5540784.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inhibitors of the Hedgehog (Hh) pathway transducer Smoothened (Smo) have been approved for cancer treatment, but Smo mutations often lead to tumor resistance and it remains unclear how Smo is regulated. In this study, we identified the small GTPase Arl13b as a novel partner and regulator of Smo. Arl13b regulated Smo stability, trafficking, and localization, which are each crucial for Hh signaling. In gastric cancer cells, Arl13b stimulated proliferation, migration, and invasion <i>in vitro</i> and <i>in vivo</i> In clinical specimens of gastric cancer, Arl13b expression correlated strongly with tumor size and depth of invasion; patients with high levels of Arl13b had a poor prognosis. Our results show how Arl13b participates in Hh pathway activation in gastric cancer. <i>Cancer Res; 77(15); 4000-13. ©2017 AACR</i>.
Medical subject headings
- ADP-Ribosylation Factors
- Carcinogenesis
- Smoothened Receptor
- Stomach Neoplasms